News
Rhenus Air & Ocean gains GDP certification at Schiphol Airport
Rhenus Air & Ocean’s pharma-focused business site at Amsterdam Airport Schiphol (AMS) has gained the Good Distribution Practice (GDP) certificate.
The Dutch headquarters of Rhenus, which has been IATA CEIV Pharma accredited for years, follows the footsteps of the business...
Clinical Trials
Ceapro Inc. Receives Approval from Health Canada to Commence Phase 1/2a Human Clinical Trial Assessing Avenanthramide Tablets
Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has received approval from Health Canada to initiate its Phase 1/2a study evaluating the safety, tolerability, bioavailabilty...
News
KangaBio and Aton Biotech Enter Into Development and Manufacturing Strategic Collaboration
Aton Biotech, a CDMO committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform, and KangaBio have announced a strategic collaboration.
Both parties aim to share resources and achieve joint development on the principle of equality and...
Drug Research
Lilly and ProQR to Expand RNA Editing Collaboration
Eli Lilly and Company and ProQR Therapeutics N.V. announced the expansion of their licensing and collaboration agreement focused on the discovery, development and commercialization of new genetic medicines.
The collaboration, originally announced in September 2021, applied ProQR’s proprietary Axiomer® RNA editing...
Drug Research
Berkshire Sterile Manufacturing Expands Testing & Development Capabilities
Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand its testing and development capabilities.
While the company’s primary service offering is sterile filtration and filling of parenterals, BSM also provides...
Drug Research
Micro-Sphere Launches R&D Lab in Switzerland
Global contract development and manufacturing organization Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.
Located within its facility in Monteggio, Switzerland, the new R&D department will specialize...
Drug Research
Asymchem Opens New R&D Site Near Boston
Asymchem Laboratories (Tianjin) Co. Ltd., a CDMO serving the global pharmaceutical and biotech industry, has opened a new site in Woburn, Massachusetts.
Asymchem Boston, a wholly owned subsidiary of Asymchem Group, marks an important step toward expanding Asymchem's global footprint....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.